头颈部放疗后味觉功能障碍的系统综述
该系统综述纳入31项研究,评估头颈部癌放疗后味觉功能障碍的患病率及影响因素。客观测量的急性味觉障碍患病率约96%(95%CI 64-100%),主观测量约79%(95%CI 65-88%),约25%患者存在长期障碍,且与体重下降和生活质量降低相关。口腔特别是舌前三分之二受照时味觉障碍更常见,质子束治疗和定制咬合块可减少味觉野剂量。
要点
- 放疗后急性味觉障碍客观患病率约96%,主观约79%,多数患者部分恢复。
- 约25%患者存在长期味觉障碍,与体重下降和生活质量降低相关。
- 口腔及舌前三分之二受照时味觉障碍更常见,提示剂量约束可行。
核心结论
- 头颈部放疗后味觉功能障碍常见,对营养状态和生活质量有负面影响。
- 治疗策略选择包括放疗模式、味觉野剂量分布和辅助装置如咬合块可能有益,但证据有限。
- 迫切需要随机研究或充分校正混杂因素的大型前瞻性队列研究。
研究设计与样本
- 系统综述,检索PubMed、Medline和EMBASE中关于味觉、放疗和头颈癌的文献。
- 纳入随机试验、队列研究和横断面研究,共31项研究。
主要发现
- 放疗后急性味觉障碍的荟萃分析患病率客观测量约96%(95%CI 64-100%),主观测量约79%(95%CI 65-88%)。
- 大多数患者显示至少部分恢复,约25%患者存在长期功能障碍。
- 味觉障碍与体重下降和生活质量降低等后遗症相关。
- 口腔特别是舌前三分之二受照时味觉障碍更常见,提示味觉保护的剂量约束可能可行。
- 质子束治疗和定制咬合块可减少味觉野剂量和后续味觉丧失。
关键数值与推荐
- 急性味觉障碍客观患病率约96%(95%CI 64-100%),主观患病率约79%(95%CI 65-88%)。
- 长期味觉障碍见于约25%的患者。
临床怎么用
- 考虑选择质子束治疗等放疗模式以减少味觉野剂量。
- 使用定制咬合块等辅助装置可能有助于保护味觉。
- 关注口腔及舌前三分之二的剂量约束,可能减少味觉障碍。
局限性
- 证据有限,需要随机研究或大型前瞻性队列研究且充分校正混杂因素。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An intact sense of taste provides pleasure, supports sustenance and alerts the body to toxins. Head and neck cancer (HNC) patients who receive radiotherapy (RT) are high-risk for developing radiation-induced taste dysfunction. Advances in RT offer opportunities for taste-preserving strategies by reducing dose to the gustatory organs-at-risk. METHODS: PubMed, Medline and EMBASE were searched for publications reporting on taste, RT and HNC. Randomised trials, cohort studies and cross-sectional studies were included. RESULTS: 31 studies were included in this review. Meta-analysed prevalence of acute taste dysfunction following RT was approximately 96% (95% CI 64 to 100%) by objective measures and 79% (95% CI 65 to 88%) by subjective measures, with the majority of patients showing at least partial recovery. Long-term dysfunction was seen in ~25% of patients. Taste dysfunction was associated with sequalae including weight loss and reduced quality-of-life (QoL). Taste dysfunction was more common when the oral cavity, and specifically the anterior two-thirds of the tongue, was irradiated, suggesting a dose constraint for taste preservation might be feasible. Proton beam therapy and customised bite blocks reduced dose to the gustatory field and subsequent loss of taste. CONCLUSIONS: Taste dysfunction following RT is common and negatively affects patients' nutritional status and QoL. Decisions about treatment strategies, including choice of RT modality, dose distribution across the gustatory field and the use of adjuncts like bite blocks may be beneficial. However, evidence is limited. There is a pressing need for randomised studies or large prospective cohort studies with sufficient adjustment for confounders.
引用
- Gunn L, Gilbert J, Nenclares P, et al. Taste dysfunction following radiotherapy to the head and neck: A systematic review. Radiother Oncol. 2021. PMID: 33545253. doi:10.1016/j.radonc.2021.01.021
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。